TREATMENT PATTERNS OF BIOLOGICS AND APREMILAST AMONG PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS BY PSORIATIC ARTHRITIS STATUS

被引：0
作者：
Feldman, S. R. [1 ]
Zhang, J. [2 ]
Martinez, D. [3 ]
Lopez-Gonzalez, L. [4 ]
Marchlewicz, E. [5 ]
Shrady, G. [4 ]
Lowry, S. [2 ]
Mendelsohn, A. B. [2 ]
Zhao, Y. [2 ]
机构：
[1] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA
[2] Sun Pharmaceut Ind Inc, Princeton, NJ USA
[3] IBM Watson Hlth, Bethesda, MD USA
[4] IBM Watson Hlth, Cambridge, MA USA
[5] IBM Watson Hlth, Ann Arbor, MI USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
10.1016/j.jval.2019.04.123
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PBI41
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [31] BUDGET IMPACT OF APREMILAST FOR MODERATE TO SEVERE PLAQUE PSORIASIS IN THE UK
    Mughal, F.
    Damera, V
    Gagnon, J.
    VALUE IN HEALTH, 2016, 19 (07) : A564 - A564
  • [32] Cost per response analysis of deucravacitinib versus apremilast and first-line biologics among patients with moderate to severe plaque psoriasis in the United States
    Park, Sang Hee
    Lambton, Mark
    Schmier, Jordana
    Hovland, Sara
    Wittstock, Keith
    Patel, Vardhaman
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
  • [33] Incremental burden of psoriatic arthritis is substantial among patients with mild and moderate to severe psoriasis
    Merola, Joseph
    Guerin, Annie
    Jarvis, John Lovell
    Wang, Ke
    Sundaram, Murali
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB173 - AB173
  • [34] Apremilast: A Novel Oral Treatment for Psoriasis and Psoriatic Arthritis
    Tiago Torres
    Luis Puig
    American Journal of Clinical Dermatology, 2018, 19 : 23 - 32
  • [35] Update on the treatment of psoriasis and psoriatic arthritis - role of apremilast
    Forchhammer, Stephan
    Ghoreschi, Kamran
    PSORIASIS-TARGETS AND THERAPY, 2015, 5 : 117 - 124
  • [36] Apremilast: A Novel Drug for Treatment of Psoriasis and Psoriatic Arthritis
    Haber, Stacy L.
    Hamilton, Sarah
    Bank, Mark
    Leong, Shi Yun
    Pierce, Evelyn
    ANNALS OF PHARMACOTHERAPY, 2016, 50 (04) : 282 - 290
  • [37] Adalimumab efficacy and safety results in patients with moderate to severe chronic plaque psoriasis with and without psoriatic arthritis
    Menter, MA
    Gordon, K
    Leonardi, C
    Chen, D
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P174 - P174
  • [38] Apremilast: A Novel Oral Treatment for Psoriasis and Psoriatic Arthritis
    Torres, Tiago
    Puig, Luis
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2018, 19 (01) : 23 - 32
  • [39] Treatment patterns in moderate to severe plaque psoriasis patients with multiple biologic failures
    Gulliver, Wayne
    Gulliver, Susanne R.
    DiBattista, Michelle
    Power, Rebecca
    Green, Rebecca
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB141 - AB141
  • [40] Treatment persistence of biologics among patients with psoriatic arthritis
    Haddad, Amir
    Gazitt, Tal
    Feldhamer, Ilan
    Feld, Joy
    Cohen, Arnon Dov
    Lavi, Idit
    Tatour, Faten
    Bergman, Irena
    Zisman, Devy
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
12345